Clinical Trial: Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide

U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07537699) titled 'Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide' on Dec. 11, 2025.

Brief Summary: The goal of this clinical trial is to learn if auricular point stimulation plus dexamethasone works to effectively prevent or suppress nausea and vomiting caused by docetaxel combined with cyclophosphamide in breast cancer adjuvant chemotherapy. It will also learn about the safety and influence on gastrointestinal function of auricular point stimulation plus dexamethasone.

The main questions it aims to answer are:

Can auricular point stimulation plus dexamethasone effectively prevent o...